Annemiek M. Van Maldegem
Leiden, ZH 2300RC, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).
Journal: BMC cancer
Published: March 23, 2022
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma.
Journal: The oncologist
Published: October 30, 2017
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: June 29, 2016
Panobinostat-A Potential Treatment for Metastasized Ewing Sarcoma? A Case Report.
Journal: Pediatric blood & cancer
Published: January 13, 2016
Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 26, 2015
Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013.
Journal: Clinical sarcoma research
Published: July 10, 2014
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
Journal: Pediatric blood & cancer
Published: March 13, 2014
Outcome of advanced, unresectable conventional central chondrosarcoma.
Journal: Cancer
Published: November 20, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026